Jurisdictional control of public health policies through the inclusion of medicines in the list of essential medicines of the Unified Health System

被引:0
|
作者
Dal Pozzo, Emerson Luis [1 ]
Mion, Ronaldo de Paula [2 ]
机构
[1] Ctr Univ Curitiba, UNICURITIBA, Curitiba, Parana, Brazil
[2] Univ Fed Parana, Direito, Curitiba, Parana, Brazil
关键词
Fundamental right to health; Medicines; Objective dimension; Public policy; Jurisdictional control; INSTITUTIONAL DIALOGUES; FUNDAMENTAL RIGHT; JUDICIAL CONTROL; SUPREME-COURT; RIGHTS; CONSTITUTIONALISM; BRAZIL; LIMITS;
D O I
10.21056/aec.v19i77.1113
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
The supply of medicines is one of the pretensions that derive from the fundamental social right to health, and to promote this right and balance the public accounts, the State - through the Unified Health System - uses an important instrument, that is the List of Essential Medicines. The medicines lists enumerate the drugs that must meet the health priorities of the Brazilian population, and thus are part of public health policy strategies. Usually, essential medicines are not in the lists, which entails numerous judicial demands of an individual nature, many of them involving the same drug. From the objective dimension of fundamental rights, we intend to develop in this study an analysis about the possibility of carrying out judicial control of public policies through collective that mandate the State the inclusion of a specific drug in the list of essential medicines.
引用
收藏
页码:199 / 228
页数:30
相关论文
共 50 条
  • [31] Essential medicines for universal health coverage
    Tanimoto, Tetsuya
    Tsuda, Kenji
    Kurokawa, Tomohiro
    Mori, Jinichi
    Shimmura, Hiroaki
    LANCET, 2017, 389 (10082): : 1880 - 1881
  • [32] Essential medicines for universal health coverage
    Wirtz, Veronika J.
    Hogerzeil, Hans V.
    Gray, Andrew L.
    Bigdeli, Maryam
    de Joncheere, Cornelis P.
    Ewen, Margaret A.
    Gyansa-Lutterodt, Martha
    Jing, Sun
    Luiza, Vera L.
    Mbindyo, Regina M.
    Moller, Helene
    Moucheraud, Corrina
    Pecoul, Bernard
    Rago, Lembit
    Rashidian, Arash
    Ross-Degnan, Dennis
    Stephens, Peter N.
    Teerawattananon, Yot
    't Hoen, Ellen F. M.
    Wagner, Anita K.
    Yadav, Prashant
    Reich, Michael R.
    LANCET, 2017, 389 (10067): : 403 - 476
  • [33] World Health Organization and Essential Medicines
    Dugani, Sagar
    Wasan, Kishor M.
    Kissoon, Niranjan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (05) : 1261 - 1262
  • [34] WHO essential medicines for reproductive health
    Gill, Roopan
    Ganatra, Bela
    Althabe, Fernando
    BMJ GLOBAL HEALTH, 2019, 4 (06):
  • [35] Right to health, essential medicines, and lawsuits for access to medicines - A scoping study
    Vargas-Pelaez, Claudia Marcela
    Mattozo Rover, Marina Raijche
    Leite, Silvana Nair
    Rossi Buenaventura, Francisco
    Farias, Mareni Rocha
    SOCIAL SCIENCE & MEDICINE, 2014, 121 : 48 - 55
  • [36] Public health issues with counterfeit medicines
    Feldschreiber, Peter
    CLINICAL MEDICINE, 2009, 9 (01) : 63 - 64
  • [37] Patent medicines and the public's health
    Parascandola, J
    PUBLIC HEALTH REPORTS, 1999, 114 (04) : 318 - 321
  • [39] Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases
    Kishore, Sandeep P.
    Blank, Evan
    Heller, David J.
    Patel, Amisha
    Peters, Alexander
    Price, Matthew
    Vidula, Mahesh
    Fuster, Valentin
    Onuma, Oyere
    Huffman, Mark D.
    Vedanthan, Rajesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (05) : 564 - 574
  • [40] "Know your medicines, know your health"-public perspectives on medicines and health awareness campaigns
    Alhomoud, Faten
    Alameer, Kawthar
    Almousa, Zahra'a
    Almatar, Manar
    Alzlaiq, Wafa
    Alhomoud, Farah Kais
    Alsugeir, Dana
    FRONTIERS IN PUBLIC HEALTH, 2025, 13